Loading…
α-Glucosidase Inhibitors From the Coral-Associated Fungus Aspergillus terreus
Nine novel butenolide derivatives, including four pairs of enantiomers, named (±)-asperteretones A-D ( ), and a racemate, named asperteretone E ( ), were isolated and identified from the coral associated fungus . All the structures were established based on extensive spectroscopic analyses, includin...
Saved in:
Published in: | Frontiers in chemistry 2018-09, Vol.6, p.422-422 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Nine novel butenolide derivatives, including four pairs of enantiomers, named (±)-asperteretones A-D (
), and a racemate, named asperteretone E (
), were isolated and identified from the coral
associated fungus
. All the structures were established based on extensive spectroscopic analyses, including HRESIMS and NMR data. The chiral chromatography analyses allowed the separation of (±)-asperteretones A-D, whose absolute configurations were further confirmed by experimental and calculated electronic circular dichroism (ECD) analysis. Structurally, compounds
-
represented the first examples of prenylated γ-butenolides bearing 2-phenyl-3-benzyl-4
-furan-1-one motifs, and their crucial biogenetically related metabolite, compound
, was uniquely defined by an unexpected cleavage of oxygen bridge between C-1 and C-4. Importantly, (±)-asperteretal D and (4
)-4-decarboxylflavipesolide C were revised to (±)-asperteretones B (
/
) and D (
), respectively. Additionally, compounds
and
were evaluated for the α-glucosidase inhibitory activity, and all these compounds exhibited potent inhibitory potency against α-glucosidase, with IC
values ranging from 15.7 ± 1.1 to 53.1 ± 1.4 μM, which was much lower than that of the positive control acarbose (IC
= 154.7 ± 8.1 μM), endowing them as promising leading molecules for the discovery of new α-glucosidase inhibitors for type-2 diabetes mellitus treatment. |
---|---|
ISSN: | 2296-2646 2296-2646 |
DOI: | 10.3389/fchem.2018.00422 |